Intech Investment Management LLC reduced its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 34.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,087 shares of the medical instruments supplier's stock after selling 3,235 shares during the quarter. Intech Investment Management LLC's holdings in West Pharmaceutical Services were worth $1,827,000 as of its most recent SEC filing.
Several other hedge funds have also added to or reduced their stakes in WST. LGT Group Foundation bought a new stake in shares of West Pharmaceutical Services during the 2nd quarter valued at $68,854,000. Liontrust Investment Partners LLP bought a new stake in shares of West Pharmaceutical Services during the 2nd quarter valued at about $64,196,000. Sei Investments Co. boosted its holdings in West Pharmaceutical Services by 12.7% in the second quarter. Sei Investments Co. now owns 401,026 shares of the medical instruments supplier's stock worth $132,095,000 after acquiring an additional 45,208 shares in the last quarter. Canada Pension Plan Investment Board raised its stake in shares of West Pharmaceutical Services by 25.0% in the second quarter. Canada Pension Plan Investment Board now owns 207,564 shares of the medical instruments supplier's stock worth $68,370,000 after purchasing an additional 41,454 shares during the last quarter. Finally, Kayne Anderson Rudnick Investment Management LLC increased its position in shares of West Pharmaceutical Services by 6.8% during the second quarter. Kayne Anderson Rudnick Investment Management LLC now owns 593,692 shares of the medical instruments supplier's stock valued at $195,556,000 after acquiring an additional 37,702 shares during the last quarter. Institutional investors own 93.90% of the company's stock.
Insider Buying and Selling at West Pharmaceutical Services
In other West Pharmaceutical Services news, VP Charles Witherspoon sold 703 shares of West Pharmaceutical Services stock in a transaction on Tuesday, October 29th. The stock was sold at an average price of $310.40, for a total value of $218,211.20. Following the sale, the vice president now owns 1,253 shares in the company, valued at $388,931.20. The trade was a 35.94 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.53% of the stock is currently owned by company insiders.
West Pharmaceutical Services Price Performance
NYSE WST traded up $5.63 during trading hours on Monday, reaching $322.22. 168,531 shares of the stock traded hands, compared to its average volume of 571,976. The company has a market cap of $23.34 billion, a price-to-earnings ratio of 46.97, a price-to-earnings-growth ratio of 23.91 and a beta of 1.00. The stock has a 50 day simple moving average of $307.01 and a two-hundred day simple moving average of $313.91. The company has a debt-to-equity ratio of 0.07, a current ratio of 3.00 and a quick ratio of 2.23. West Pharmaceutical Services, Inc. has a 1 year low of $265.00 and a 1 year high of $413.70.
West Pharmaceutical Services (NYSE:WST - Get Free Report) last posted its earnings results on Thursday, October 24th. The medical instruments supplier reported $1.85 EPS for the quarter, topping analysts' consensus estimates of $1.50 by $0.35. West Pharmaceutical Services had a net margin of 17.37% and a return on equity of 18.41%. The business had revenue of $746.90 million during the quarter, compared to the consensus estimate of $709.62 million. During the same quarter in the previous year, the firm posted $2.16 EPS. The firm's revenue was down .1% on a year-over-year basis. On average, analysts predict that West Pharmaceutical Services, Inc. will post 6.67 EPS for the current fiscal year.
West Pharmaceutical Services Increases Dividend
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, November 20th. Investors of record on Wednesday, November 13th were paid a dividend of $0.21 per share. This is a boost from West Pharmaceutical Services's previous quarterly dividend of $0.20. This represents a $0.84 dividend on an annualized basis and a dividend yield of 0.26%. The ex-dividend date was Wednesday, November 13th. West Pharmaceutical Services's dividend payout ratio is 12.46%.
West Pharmaceutical Services Company Profile
(
Free Report)
West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.
See Also
Before you consider West Pharmaceutical Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and West Pharmaceutical Services wasn't on the list.
While West Pharmaceutical Services currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
